Kissei Pharmaceutical Co., Ltd.
Clinical trials sponsored by Kissei Pharmaceutical Co., Ltd., explained in plain language.
-
New drug shows promise for Women's fibroid pain and bleeding
Disease control CompletedThis Phase 3 study tested whether the drug KLH-2109 is better than a placebo at reducing heavy menstrual bleeding and pain in women with uterine fibroids. The trial involved 89 premenopausal Japanese women who experienced these symptoms. Researchers measured changes in bleeding a…
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
New drug trial targets debilitating itch for dialysis patients
Symptom relief CompletedThis study tested whether an investigational drug called MR13A9 could reduce severe itching in people receiving hemodialysis for kidney disease. The trial involved 178 patients who experienced significant itch despite treatment. Researchers compared MR13A9 against a placebo to se…
Phase: PHASE3 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Apr 04, 2026 06:35 UTC
-
New drug tested to relieve debilitating itch for dialysis patients
Symptom relief CompletedThis study tested an investigational drug called MR13A9 to see if it could safely reduce severe itching in people receiving hemodialysis for kidney disease. It involved 247 Japanese patients who experienced significant itch despite treatment. Researchers compared different doses …
Phase: PHASE2 • Sponsor: Kissei Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Mar 11, 2026 14:54 UTC